140 related articles for article (PubMed ID: 37267678)
1. Incidence, trends, and survival of oropharyngeal squamous cell cancer in Aotearoa New Zealand, 2006-2020.
Win Myint TT; McIvor N; Douglas R; Tin Tin S; Elwood M
Cancer Epidemiol; 2023 Aug; 85():102393. PubMed ID: 37267678
[TBL] [Abstract][Full Text] [Related]
2. Comparison of oropharyngeal and oral cavity squamous cell cancer incidence and trends in New Zealand and Queensland, Australia.
Elwood JM; Youlden DR; Chelimo C; Ioannides SJ; Baade PD
Cancer Epidemiol; 2014 Feb; 38(1):16-21. PubMed ID: 24445141
[TBL] [Abstract][Full Text] [Related]
3. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009.
Forte T; Niu J; Lockwood GA; Bryant HE
Cancer Causes Control; 2012 Aug; 23(8):1343-8. PubMed ID: 22718355
[TBL] [Abstract][Full Text] [Related]
4. Trends in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma Incidence, Vermont 1999-2013.
Owosho AA; Wiley R; Stansbury T; Gbadamosi SO; Ryder JS
J Community Health; 2018 Aug; 43(4):731-737. PubMed ID: 29427129
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological trends of oropharyngeal and oral cavity squamous cell carcinomas in Northern New England, 2000-2013.
Owosho AA; Velez M; Tyburski A; Hofheins J; Wiley R; Stansbury T; Gbadamosi SO; Ryder JS
Cancer Causes Control; 2019 Mar; 30(3):291-299. PubMed ID: 30729358
[TBL] [Abstract][Full Text] [Related]
6. Sociodemographic differences in the incidence of oropharyngeal and oral cavity squamous cell cancers in New Zealand.
Chelimo C; Elwood JM
Aust N Z J Public Health; 2015 Apr; 39(2):162-7. PubMed ID: 25827186
[TBL] [Abstract][Full Text] [Related]
7. Incidence, Trends and Ethnic Differences of Oropharyngeal, Anal and Cervical Cancers: Singapore, 1968-2012.
Lam JO; Lim WY; Chow KY; D'Souza G
PLoS One; 2015; 10(12):e0146185. PubMed ID: 26720001
[TBL] [Abstract][Full Text] [Related]
8. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
[TBL] [Abstract][Full Text] [Related]
9. Distress levels in patients with oropharyngeal vs. non-oropharyngeal squamous cell carcinomas of the head and neck over 1 year after diagnosis: a retrospective cohort study.
Schorr M; Carlson LE; Lau HY; Zhong L; Bultz BD; Waller A; Groff SL; Hao D
Support Care Cancer; 2017 Oct; 25(10):3225-3233. PubMed ID: 28600705
[TBL] [Abstract][Full Text] [Related]
10. The epidemiology of head and neck squamous cell carcinoma in The Netherlands during the era of HPV-related oropharyngeal squamous cell carcinoma. Is there really evidence for a change?
van Monsjou HS; Schaapveld M; van den Brekel MW; Balm AJ
Oral Oncol; 2015 Oct; 51(10):901-7. PubMed ID: 26216340
[TBL] [Abstract][Full Text] [Related]
11. Temporal trends in oropharyngeal cancer incidence, survival, and cancer-directed surgery among elderly Americans.
Chidambaram S; Hong SA; Simpson MC; Osazuwa-Peters N; Ward GM; Massa ST
Oral Oncol; 2022 Nov; 134():106132. PubMed ID: 36191478
[TBL] [Abstract][Full Text] [Related]
12. The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma.
Liederbach E; Kyrillos A; Wang CH; Liu JC; Sturgis EM; Bhayani MK
Int J Cancer; 2017 Feb; 140(3):504-512. PubMed ID: 27667729
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and Patient Distribution of Oral Cavity and Oropharyngeal SCC in Canada.
Ghazawi FM; Lu J; Savin E; Zubarev A; Chauvin P; Sasseville D; Zeitouni A; Litvinov IV
J Cutan Med Surg; 2020; 24(4):340-349. PubMed ID: 32238063
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status.
Faraji F; Rettig EM; Tsai HL; El Asmar M; Fung N; Eisele DW; Fakhry C
Cancer; 2019 Mar; 125(5):761-769. PubMed ID: 30521092
[TBL] [Abstract][Full Text] [Related]
15. Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis.
Diaz DA; Reis IM; Weed DT; Elsayyad N; Samuels M; Abramowitz MC
Head Neck; 2016 Apr; 38 Suppl 1():E873-83. PubMed ID: 25966421
[TBL] [Abstract][Full Text] [Related]
16. A cross-sectional survey of awareness of human papillomavirus-associated oropharyngeal cancers among general practitioners in the UK.
Lechner M; Vassie C; Kavasogullari C; Jones O; Howard J; Masterson L; Fenton T; Yarbrough W; Waller J; Gilson R
BMJ Open; 2018 Jul; 8(7):e023339. PubMed ID: 30056394
[TBL] [Abstract][Full Text] [Related]
17. Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.
Windon MJ; D'Souza G; Rettig EM; Westra WH; van Zante A; Wang SJ; Ryan WR; Mydlarz WK; Ha PK; Miles BA; Koch W; Gourin C; Eisele DW; Fakhry C
Cancer; 2018 Jul; 124(14):2993-2999. PubMed ID: 29710393
[TBL] [Abstract][Full Text] [Related]
18. Incidence trends in head and neck squamous cell carcinoma in Slovenia, 1983-2009: role of human papillomavirus infection.
Strojan P; Zadnik V; Šifrer R; Lanišnik B; Didanović V; Jereb S; Poljak M; Kocjan BJ; Gale N
Eur Arch Otorhinolaryngol; 2015 Dec; 272(12):3805-14. PubMed ID: 25542247
[TBL] [Abstract][Full Text] [Related]
19. Projected Association of Human Papillomavirus Vaccination With Oropharynx Cancer Incidence in the US, 2020-2045.
Zhang Y; Fakhry C; D'Souza G
JAMA Oncol; 2021 Oct; 7(10):e212907. PubMed ID: 34473210
[TBL] [Abstract][Full Text] [Related]
20. Incidence of Oropharyngeal Cancer Among Elderly Patients in the United States.
Zumsteg ZS; Cook-Wiens G; Yoshida E; Shiao SL; Lee NY; Mita A; Jeon C; Goodman MT; Ho AS
JAMA Oncol; 2016 Dec; 2(12):1617-1623. PubMed ID: 27415639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
